Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain study tests if sound or touch can replace sight

NCT ID NCT07450677

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study at Stanford University will test how the brain responds when visual information is turned into patterns of sound or touch. Two hundred blind and sighted participants will use special devices (BrainPort and AI Sight) for 5 weeks. Researchers will use brain scans and performance tasks to see how people learn and adapt to these sensory substitutions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Electrotactile display (BrainPort) and vision-to-sound converter (AI Sight) devices
What this could lead to
If successful, this could help improve assistive technologies for blind individuals by understanding how the brain processes non-visual sensory information.
What could go wrong
This is an early-stage observational study, not a treatment trial. It may not lead to any direct clinical benefit, and results may not apply to all types of blindness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Aug 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

8 to 85 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. 8-85 years old for blind individuals; or 18-85 years old for sighted controls. 2. (a) Blind due to ocular impairment (documented visual acuity of light perception or worse) in both eyes, or (b) sighted healthy adult controls with corrected visual acuity of 20/40 or better and with no known vision disorders. 3. Able to hear the Informed Consent Form being read out to him or her, to understand it, and sign the Informed Consent Form. 4. Able to undergo functional neuroimaging tests. 5. Able to walk and stand independently. 6. Able to understand and remember the training protocols involved in the research study. 7. Willing and able to use the provided sensory substitution system to solve simple visual tasks. 8. Willing and able to complete simple tactile or auditory tasks. 9. Able to communicate by telephone and/or computer with research staff. Exclusion Criteria: 1. Prior use with the sensory substitution device under investigation. This applies to both the auditory and tactile stimulators. 2. Presence of any foreign metal in the body, except for dental fillings (will need to be pre-screened by a radiologist prior to signing the informed consent and enrollment). 3. Pregnant or breastfeeding by self-report or urine test. 4. Is a prisoner or has any required movements legally restricted. 5. Unwilling or unable to adhere to all study requirements, including completion of the training period and any evaluation tests. 6. Implanted electrical medical devices such as pacemakers. 7. Claustrophobia that would prevent functional neuroimaging. 8. Obesity preventing placement in the MRI scanner. 9. No known neurological disorders or any medical condition that can possibly lead to emergency medical care (e.g., history of seizures, family history of epilepsy, stroke, severe headaches, use of medication for neurological or psychiatric conditions). 10. Documented or suspected brain damage resulting in significant cognitive or sensory impairment (e.g., traumatic brain injury).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Blindness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    2 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Byers Eye Institute at Stanford University

    Palo Alto, California, 94303, United States

  • LUCAS Center for Imaging

    Stanford, California, 94305, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.